Profile of Daprodustat in the Treatment of Renal Anemia Due to Chronic Kidney Disease
Taisuke Ishii, Tetsuhiro Tanaka, Masaomi Nangaku Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, JapanCorrespondence: Masaomi NangakuDivision of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunky...
Main Authors: | Ishii T, Tanaka T, Nangaku M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-02-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/profile-of-daprodustat-in-the-treatment-of-renal-anemia-due-to-chronic-peer-reviewed-article-TCRM |
Similar Items
-
Stabilizing Hypoxia-Inducible Factor to Manage Anemia in Chronic Kidney Disease: From Basic Theory to Clinical Study
by: Yudian Wang, et al.
Published: (2024-01-01) -
Efficacy and Safety of Vadadustat for Anemia in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis
by: Limei Xiong, et al.
Published: (2022-01-01) -
REGULATION OF BONE MARROW ANGIOGENESIS BY OSTEOBLASTS DURING BONE DEVELOPMENT AND HOMEOSTASIS
by: Ernestina eSchipani, et al.
Published: (2013-07-01) -
mRNA expression profile of selected oxygen sensing genes in the lung during recovery from chronic hypoxia
by: Alice Panariti, et al.
Published: (2013-01-01) -
A Phase 3 Study of Enarodustat (JTZ-951) in Japanese Hemodialysis Patients for Treatment of Anemia in Chronic Kidney Disease: SYMPHONY HD Study
by: Tadao Akizawa, et al.
Published: (2021-07-01)